Puma Biotechnology, Inc.
US ˙ NasdaqGS ˙ US74587V1070

Introduction

This page provides a comprehensive analysis of the known insider trading history of Maximo F Nougues. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Maximo F Nougues has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PBYI / Puma Biotechnology, Inc. Chief Financial Officer 204,229
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Maximo F Nougues. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PBYI / Puma Biotechnology, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PBYI / Puma Biotechnology, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PBYI / Puma Biotechnology, Inc. Insider Trades
Insider Sales PBYI / Puma Biotechnology, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PBYI / Puma Biotechnology, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-01-03 PBYI NOUGUES MAXIMO F 10,499 4.1779 10,499 4.1779 43,864 79 2.2100 -20,660 -47.10
2022-12-02 PBYI NOUGUES MAXIMO F 159 4.4978 159 4.4978 715
2022-11-02 PBYI NOUGUES MAXIMO F 163 2.2500 163 2.2500 367
2022-10-03 PBYI NOUGUES MAXIMO F 165 2.3354 165 2.3354 385
2022-09-02 PBYI NOUGUES MAXIMO F 164 2.5896 164 2.5896 425
2022-07-05 PBYI NOUGUES MAXIMO F 5,835 2.6315 5,835 2.6315 15,355
2022-07-05 PBYI NOUGUES MAXIMO F 9,328 2.6315 9,328 2.6315 24,547
2022-06-02 PBYI NOUGUES MAXIMO F 162 1.9218 162 1.9218 311
2022-05-03 PBYI NOUGUES MAXIMO F 165 2.3401 165 2.3401 386
2022-05-03 PBYI NOUGUES MAXIMO F 165 2.3401 165 2.3401 386
2022-05-03 PBYI NOUGUES MAXIMO F 165 2.3401 165 2.3401 386
2022-04-04 PBYI NOUGUES MAXIMO F 206 3.0780 206 3.0780 634
2022-03-02 PBYI NOUGUES MAXIMO F 169 2.2620 169 2.2620 382
2022-02-02 PBYI NOUGUES MAXIMO F 199 2.4822 199 2.4822 494
2022-01-03 PBYI NOUGUES MAXIMO F 7,484 3.1896 7,484 3.1896 23,871
2021-12-02 PBYI NOUGUES MAXIMO F 162 2.9500 162 2.9500 478
2021-11-02 PBYI NOUGUES MAXIMO F 156 5.6710 156 5.6710 885
2021-10-04 PBYI NOUGUES MAXIMO F 161 6.2001 161 6.2001 998
2021-09-02 PBYI NOUGUES MAXIMO F 155 7.5110 155 7.5110 1,164
2021-08-02 PBYI NOUGUES MAXIMO F 154 7.5421 154 7.5421 1,161
2021-07-02 PBYI NOUGUES MAXIMO F 155 9.2588 155 9.2588 1,435
2021-06-02 PBYI NOUGUES MAXIMO F 152 10.7410 152 10.7410 1,633
2021-05-03 PBYI NOUGUES MAXIMO F 152 9.9104 152 9.9104 1,506
2021-04-05 PBYI NOUGUES MAXIMO F 155 9.8029 155 9.8029 1,519
2021-03-02 PBYI NOUGUES MAXIMO F 154 10.1356 154 10.1356 1,561
2021-02-02 PBYI NOUGUES MAXIMO F 179 12.2607 179 12.2607 2,195
2021-01-04 PBYI NOUGUES MAXIMO F 2,145 10.2239 2,145 10.2239 21,930

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PBYI / Puma Biotechnology, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Maximo F Nougues as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-10 2025-07-09 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -3,935 204,229 -1.89 3.54 -13,910 721,950
2025-07-10 2025-07-08 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -5,587 208,164 -2.61 3.53 -19,739 735,443
2025-02-11 2025-02-07 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 61,456 213,751 40.35
2025-01-03 2025-01-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -10,227 152,295 -6.29 3.15 -32,232 479,988
2024-07-18 2024-07-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -4,156 162,522 -2.49 3.70 -15,382 601,510
2024-07-02 2024-07-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -5,295 166,678 -3.08 3.27 -17,307 544,787
2024-02-14 2024-02-12 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 43,307 171,973 33.66
2024-01-05 2024-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -15,682 128,666 -10.86 4.49 -70,348 577,183
2023-07-06 2023-07-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -14,680 144,348 -9.23 3.31 -48,608 477,965
2023-02-14 2023-02-10 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 58,601 159,028 58.35
2023-01-05 2023-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -10,499 100,427 -9.46 4.18 -43,864 419,574
2022-12-06 2022-12-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -159 110,926 -0.14 4.50 -715 498,923
2022-11-04 2022-11-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -163 111,085 -0.15 2.25 -367 249,941
2022-10-05 2022-10-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -165 111,248 -0.15 2.34 -385 259,809
2022-09-07 2022-09-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -164 111,413 -0.15 2.59 -425 288,515
2022-08-04 2022-07-05 4/A PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -9,328 111,738 -7.70 2.63 -24,547 294,039
2022-08-04 2022-08-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -161 111,577 -0.14 2.89 -465 322,458
2022-07-07 2022-07-05 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -5,835 64,625 -8.28 2.63 -15,355 170,061
2022-06-06 2022-06-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -162 121,066 -0.13 1.92 -311 232,665
2022-05-04 2022-05-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -165 121,228 -0.14 2.34 -386 283,686
2022-05-04 2022-05-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -165 121,228 -0.14 2.34 -386 283,686
2022-05-04 2022-05-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -165 121,228 -0.14 2.34 -386 283,686
2022-04-05 2022-04-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -206 121,393 -0.17 3.08 -634 373,648
2022-03-14 2022-03-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 88,824 88,824
2022-03-14 2022-03-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 62,176 121,599 104.63
2022-03-04 2022-03-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -169 59,423 -0.28 2.26 -382 134,415
2022-02-03 2022-02-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -199 59,592 -0.33 2.48 -494 147,919
2022-01-05 2022-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -7,484 59,791 -11.12 3.19 -23,871 190,709
2021-12-06 2021-12-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -162 67,275 -0.24 2.95 -478 198,461
2021-11-03 2021-11-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -156 67,437 -0.23 5.67 -885 382,435
2021-10-06 2021-10-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -161 67,593 -0.24 6.20 -998 419,083
2021-09-03 2021-09-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -155 67,754 -0.23 7.51 -1,164 508,900
2021-08-03 2021-08-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -154 67,909 -0.23 7.54 -1,161 512,176
2021-07-06 2021-07-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -155 68,063 -0.23 9.26 -1,435 630,182
2021-06-04 2021-06-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -152 68,218 -0.22 10.74 -1,633 732,730
2021-05-05 2021-05-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -152 68,370 -0.22 9.91 -1,506 677,574
2021-04-06 2021-04-05 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -155 68,522 -0.23 9.80 -1,519 671,714
2021-03-04 2021-03-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -154 68,677 -0.22 10.14 -1,561 696,083
2021-02-19 2021-02-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 78,209 78,209
2021-02-19 2021-02-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 55,595 68,831 420.03
2021-02-04 2021-02-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -179 13,236 -1.33 12.26 -2,195 162,283
2021-01-06 2021-01-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -2,145 13,415 -13.79 10.22 -21,930 137,154
2020-02-13 2020-02-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 15,567 15,567
2020-02-13 2020-02-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 15,560 15,560
2018-11-13 2018-11-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 90,000 90,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)